Skip to main content

Table 1 Profile of cardiovascular medications, smoking and psychosocial status at baseline and one year post-admission

From: Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey

 

Baseline

One year

OR

95% CI

p-value

Cardiovascular Medications

     

   Aspirin

88%

87%

1.2

0.8–1.8

0.334

   Antihypertensive≪/Blood Pressure

94%

72%

6.8

4.5–10.7

<0.001***

   Statins/Cholesterol

83%

84%

0.9

0.6–1.2

0.437

Smoking status

     

   Current Smoker

40%

22%

18.9

9.3–44.5

<0.001***

   Median number of cigarettes smoked per day (IQR)

20 (18–30)

10 (7–20)

-

-

<0.001***

Psychosocial status

     

   Full/part-time employment§

64%

54%

2.7

1.6–4.6

<0.001***

   Depression≪≪

15%

17%

0.8

0.5–1.3

0.434

HADS-D

14%

19%

0.7

0.4–1.2

0.169

BDI-FS

16%

15%

1.3

0.5–2.9

0.701

  1. (*p < .05, **p < .01, ***p < .001)
  2. ≪ – includes angiotensin converting enzyme inhibitors, betablockers, calcium antagonists and diuretics
  3. § – For those patients <65 years on index admission (n = 363)
  4. ≪≪ – For those who completed a depression scale at baseline and follow-up (n = 447)
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us